Stocks · Health care · Pharmaceutical Preparations

ARS Pharmaceuticals, Inc.

SPRY Clue Score36
United States Fiscal year ends December CIK 0001671858 Results filed 5 Nov 2026

What the insiders did No buying or selling

By person

11 insiders · 0 transactions
Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Richard E Lowenthal
President and CEO
—
—
—
5,523,683
$55.24M
−6.9%
James E Flynn
10% owner
—
—
—
4,887,254
$48.87M
−21.1%
Sarina Tanimoto
Chief Medical Officer
—
—
—
4,680,959
$46.81M
−8.1%
Pratik Shah
Director
—
—
—
4,474,554
$44.75M
−7.3%
Laura Shawver
Director
—
—
—
210,346
$2.10M
0.0%
Alexander A Fitzpatrick
Chief Legal Officer
—
—
—
90,910
$909.10K
−6.5%
Eric Karas
Chief Commercial Officer
—
—
—
12,176
$121.76K
0.0%
Brian Dorsey
Chief Operating Officer
—
—
—
10,789
$107.89K
0.0%
Kathleen D. Scott
Chief Financial Officer
—
—
—
10,042
$100.42K
0.0%
Brent L Saunders
Director
—
—
—
0
$0.00
—
Justin Chakma
Chief Business Officer
—
—
—
0
$0.00
−100.0%

No percentages here. These insiders hold more than one class of share between them, and the share count on file covers one of them rather than all. Dividing the two would compare different things.